The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo (Q36688959)
Jump to navigation
Jump to search
scientific article published on 27 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo |
scientific article published on 27 October 2015 |
Statements
1 reference
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo (English)
1 reference
Frank P Vendetti
1 reference
Alan Lau
1 reference
Sandra Schamus
1 reference
Thomas P Conrads
1 reference
Mark J O'Connor
1 reference
Christopher J Bakkenist
1 reference
Identifiers
1 reference